In summary, this study identifies a conserved PTGS2-CD274-CD8A axis reproducible across transcriptomic and protein platforms, providing a biologically grounded foundation for prognostic biomarker development in CRC. This evidence concerns the gene CD8A and colorectal carcinoma.